Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.54 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.54 |
| ▸ | CTSK | P43235 | 2/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.46 |
| ▸ | MMP8 | P22894 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19177231 | 0.87 | CYP3A4 (0.43) | CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6 | |
| SCHEMBL11259061 | 0.87 | CYP3A4 (0.52) | CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6 | |
| SCHEMBL11259618 | 0.87 | CYP3A4 (0.73) | CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6 | |
| Hydrochloric Acid SCHEMBL11258201 | 0.85 | LMNA (0.74) | CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6 | |
| SCHEMBL14355533 | 0.85 | CYP3A4 (0.57) | CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6 | |
| SCHEMBL3504292 | 0.83 | NAAA (0.44) | CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6 | |
| SCHEMBL19220803 | 0.83 | CYP3A4 (0.56) | CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6 | |
| SCHEMBL19220802 | 0.83 | CYP3A4 (0.56) | CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6 | |
| SCHEMBL12390094 | 0.82 | KCNH2 (0.44) | CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6 | |
| SCHEMBL1003604 | 0.82 | CTSK (0.49) | CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4519404-A1 | METHODS FOR ENHANCING MENTAL PERFORMANCE AND COMPOSITIONS FOR USE THEREIN | Firmenich SA (CH) | 2025-03-12 | — | — | EP | disclosed |
| EP-4514477-A1 | FRAGRANCE COMPOSITIONS HAVING LONG-LASTING TRAIL PERFORMANCE | Firmenich SA (CH) | 2025-03-05 | — | — | EP | disclosed |
| WO-2023247604-A1 | METHODS FOR ENHANCING MENTAL PERFORMANCE AND COMPOSITIONS FOR USE THEREIN | FIRMENICH SA (CH) | 2023-12-28 | — | — | WO | disclosed |
| US-11674110-B2 | Compositions containing lauryl methacrylate for malodor reduction and uses thereof | AGILEX FLAVORS AND FRAGRANCES, INC (US) | 2023-06-13 | — | — | US | disclosed |
| EP-3360175-B1 | FORMULATIONS COMPRISING AT LEAST TWO ORGANIC SEMICONDUCTING COMPOUNDS AND AT LEAST TWO SOLVENTS | MERCK PATENT GMBH (DE) | 2023-05-17 | — | — | EP | disclosed |
| US-20220370328-A1 | Clear Nail Top Coat Compositions And Methods Of Making | ILNP Cosmetics Inc. (US) | 2022-11-24 | — | — | US | disclosed |
| CN-110891615-B | System and method for selecting and releasing fragrance | 阿甘香气及精细化学有限公司 | 2022-08-05 | — | — | CN | disclosed |
| US-20220241177-A1 | Clear Nail Top Coat Compositions And Methods Of Making | ILNP Cosmetics Inc. | 2022-08-04 | — | — | US | disclosed |
| EP-3325707-B1 | COMPOSITIONS FOR MALODOR REDUCTION AND USE THEREOF | AGILEX FLAVORS & FRAGRANCES INC (US) | 2021-09-29 | — | — | EP | disclosed |
| WO-2021076238-A1 | CLEAR NAIL TOP COAT COMPOSITIONS AND METHODS OF MAKING | ILNP Cosmetics Inc. (US) | 2021-04-22 | — | — | WO | disclosed |
| US-20090087401-A1 | DEODORANT COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-04-02 | — | — | US | disclosed |
| CN-100374379-C | Water treatment composition containing masking agent and method for purifying drinking water | PUR WATER PURIFICATION PROD (US) | 2008-03-12 | — | — | CN | disclosed |
| US-20060165622-A1 | Deodorant composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2006-07-27 | — | — | US | disclosed |
| CN-1750997-A | Water treatment composition containing masking agent | PUR WATER PURIFICATION PROD (US) | 2006-03-22 | — | — | CN | disclosed |
| EP-1561476-A1 | DEODORANT COMPOSITION | Takasago International Corporation (JP) | 2005-08-10 | — | — | EP | disclosed |
| EP-1067118-B1 | Cyclopentylalkyl-nitriles and the use of odoriferous cyclopentylalkyl derivatives as fragrances | GIVAUDAN SA (CH) | 2004-03-31 | — | — | EP | disclosed |
| US-6441052-B1 | ALKANOL, ALDEHYDE, AND KETONE CYCLOPENTA DERIVATIVES; FRAGRANCES | GIVAUDAN SA (CH) | 2002-08-27 | — | — | US | disclosed |
| US-6410000-B1 | PERFUME | GIVAUDAN SA (CH) | 2002-06-25 | — | — | US | disclosed |
| US-6399811-B1 | ORGANOLEPTIC | GIVAUDAN SA (CH) | 2002-06-04 | — | — | US | disclosed |
| EP-1067118-A1 | Cyclopentylalkyl-nitriles and the use of odoriferous cyclopentylalkyl derivatives as fragrances | Givaudan SA (CH) | 2001-01-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220370328-A1 | Clear Nail Top Coat Compositions And Methods Of Making | POLR1C, KAT2A, COL2A1 | CYP3A4 676/4885CYP2C9 741/4885CYP2C19 1055/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.